29 March 2021
i-nexus Global plc
("i-nexus", the "Company" or the "Group")
Director/PDMR Shareholding
i-nexus Global plc (AIM: INX), has been notified that, on 26 March 2021, David Firth, a Non-executive Director and PDMR, purchased 180,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 5.5p per share. David Firth now has a total beneficial interest in 180,000 Ordinary Shares, equivalent to approximately 0.6 per cent. of the Company's issued share capital.
For further information please contact:
| i-nexus Global plc Simon Crowther, CEO Alyson Levett, CFO
| Via: Alma PR |
| N+1 Singer (Nominated Adviser and Broker) Sandy Fraser (Corporate Finance) Tom Salvesen (Corporate Broking)
| Tel: +44 (0)207 496 3000 |
| Alma PR Caroline Forde / Robyn Fisher | Tel: +44 (0)203 405 0205 |
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a. | Name | David Firth | ||||
| 2. | Reason for the notification | |||||
| a. | Position/status | Non-executive Director | ||||
| b. | Initial notification /Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a. | Name | i-nexus Global plc | ||||
| b. | LEI | 213800QGMSEXNLYTU2g2 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a. | Description of the Financial instrument, type of instrument
Identification code | Ordinary shares of 10p each in i-nexus Global plc
ISIN: GB00BDFDLT01 | ||||
| b. | Nature of the transaction | Purchase of Ordinary Shares
| ||||
| c. | Price(s) and volume(s) |
| ||||
| d. | Aggregated information Aggregated volume Price
|
n/a
| ||||
| e. | Date of the transaction | 26/03/2021 | ||||
| f. | Place of the transaction | London Stock Exchange, XLON | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
